Morinda citrifolia (Indian Mulberry)

CONSULTATION WITH A SPECIALIST

Product code:
32 968.7 сом
We recommend installing the IMO messenger for quick contact.
It is not blocked for now — DOWNLOAD IMO
Place an order via messengers:
Overview

Morinda citrifolia (Indian Mulberry)

Product Name: Моринда цитрусолистная, Morinda citrifolia, Indische Maulbeere, Noni, Mûrier indien, نوني, ยอ

Synonyms: нони, индийская шелковица, cheese fruit, Indian mulberry, beach mulberry, große Morinde, Indische Noni, noni fruta del diablo, morinda, mûrier noni, fruit fromage, النوني، توت هندي، فاكهة الجبن، مورنيدا, มะเกลือทะเล, ลูกยอ

Main Indications for Use of Morinda citrifolia: Hyperlipidemia, essential arterial hypertension, knee osteoarthritis, chronic pain of non-inflammatory origin, irritable bowel syndrome, depressive disorder, generalized anxiety disorder, neuropathic pain, mucosal candidiasis, skin mycosis, acne vulgaris, psoriasis, allergic rhinitis, viral infection of the upper respiratory tract, herpetic infection, type 2 diabetes mellitus, metabolic syndrome.

Use of Morinda citrifolia in Mixtures and Complexes: Chronic viral hepatitis B and C, diabetic nephropathy, chronic heart failure, hypothyroidism, Alzheimer's disease, Parkinson's disease, autoimmune thyroiditis, bronchial asthma, atopic dermatitis, chronic prostatitis, ulcerative colitis, Crohn's disease, chemotherapy-induced neuropathy.

Pharmacological Properties of Morinda citrifolia: antioxidant, analgesic, anti-inflammatory, immunomodulatory, adaptogenic, hepatoprotective, antibacterial, antifungal, antiviral, anxiolytic, antidepressant, hypolipidemic, antihypertensive, hypoglycemic, antinociceptive, neuroprotective, photoprotective, wound-healing, antihistamine, anticancer.


Dosage of Pharmaceutical Forms — Morinda citrifolia

Powder — Morinda citrifolia

Indications (Powder): Hyperlipidemia, metabolic syndrome, type 2 diabetes mellitus, osteoarthritis, chronic pain syndrome, viral infection of the upper respiratory tract, mucosal candidiasis, psoriasis, generalized anxiety disorder.

Standard Dosage (Powder): 2 g of powder twice daily, 30 minutes before meals, washed down with warm water at a temperature of about 40 degrees Celsius.

Enhanced Dosage (Powder): 3 g of powder three times a day for 10 days. Recommended for pronounced metabolic syndrome, severe forms of hyperlipidemia, and acute inflammatory syndrome in osteoarthritis.

Maximum Dosage (Powder): No more than 15 g of powder per day. Permitted short-term (up to 3 days) for pronounced neuropathic pain accompanied by insulin resistance or viral load.

Preventive Dosage (Powder): 1 g of powder once daily, in the morning, on an empty stomach. Recommended for chronic hyperglycemia, stress-induced lipid metabolism disorders, and in persons over 50 years of age with excess body weight. Course — 30 days, then a break of 10 days, repeated cycles are possible.

Pediatric Dosage (Powder): Permitted from 7 years of age, with a body weight from 25 kg. Dosage — 500 mg of powder once daily in the morning, according to indications (e.g., atopic dermatitis, obesity in children).

Contraindications (Powder): Acute renal failure, hyperkalemia, active form of gastritis with increased acidity. Data on contraindications during pregnancy, lactation, and in childhood under 7 years of age have not been scientifically registered.

Side Effects (Powder): In case of overdose, the development of hyperkalemia, diarrhea, and headache is possible. Cases of increased diuresis and decreased blood pressure have been scientifically registered.

Adjustment for Patient Body Weight (Powder): For body weight below 60 kg, reduce the dosage by 25%. For body weight above 90 kg, a correction upward to 120% of the standard dose is possible under specialist supervision.

Preparation Method (Powder): To prepare 100 g of powder, the following are required: 500 g of fresh Morinda citrifolia fruits. The fruits are thoroughly washed, the skin and seeds are removed, and they are cut into thin slices. Dried in a dehydrator at a temperature not exceeding 42 degrees Celsius for 36–48 hours until completely brittle. After cooling, ground in a mill to a fine homogeneous powder. Sifted. Stored in an airtight dark glass jar.

Storage Conditions and Shelf Life (Powder): Store in a tightly closed glass container, in a dry place at a temperature of 5 to 25 degrees Celsius, without access to direct sunlight and away from electromagnetic sources. Shelf life — 12 months. After opening, use within 45 days.


Dry Extract — Morinda citrifolia

Indications (Dry Extract): Type 2 diabetes mellitus, knee osteoarthritis, chronic inflammatory pain, acne vulgaris, psoriasis, depressive disorder, generalized anxiety disorder, viral infection of the upper respiratory tract, herpetic infection, hyperlipidemia.

Standard Dosage (Dry Extract): 300 mg of dry extract (standardized for scopoletin and iridoids) twice daily after meals. Washed down with 100 ml of warm water.

Enhanced Dosage (Dry Extract): 400–500 mg of dry extract three times a day. Used for severe forms of insulin resistance, inflammatory psoriasis, and pronounced pain in arthrosis.

Maximum Dosage (Dry Extract): Up to 2 g of dry extract per day. Used short-term (no more than 5 days) for pronounced pain syndromes or viral infection with fever.

Preventive Dosage (Dry Extract): 150 mg once daily in the morning, for 20–30 days. Recommended for patients with initial hyperglycemia, in the premenopausal period, and with seasonal immunodeficiencies.

Pediatric Dosage (Dry Extract): From 12 years of age, with a body weight from 35 kg. 100 mg once daily. Under 12 years of age, use only under specialist supervision.

Contraindications (Dry Extract): Acute renal failure, active form of peptic ulcer, severe hypotension. Data on contraindications during pregnancy, lactation, and in children under 12 years of age are insufficient for scientific conclusions.

Side Effects (Dry Extract): Dyspepsia, headache, and decreased blood pressure are possible. Rare cases of allergic rash and transient drowsiness have been scientifically recorded when the dose is exceeded.

Adjustment for Patient Body Weight (Dry Extract): For patients up to 60 kg, a 25% dosage reduction is recommended. For body weight above 90 kg, an increase to 600 mg per dose is possible.

Preparation Method (Dry Extract): To obtain 100 g of dry extract, 1 kg of fresh ripe fruits is taken. The crushed raw material is subjected to maceration in 60% ethanol in a 1:3 ratio for 72 hours at a temperature of 25–30 degrees Celsius. Then the suspension is filtered and evaporated under vacuum to a thick mass. Dried at a temperature not exceeding 45 degrees in a drying chamber, followed by grinding to a powder-like state. The resulting extract is standardized for scopoletin content (at least 0.1%) and iridoids (at least 1%).

Storage Conditions and Shelf Life (Dry Extract): Store in a tightly sealed dark glass container, at a temperature not exceeding 25 degrees Celsius, under conditions of low humidity and protection from light and electromagnetic fields. Shelf life — 18 months. After opening the package, use within 30 days.


Alcohol-Based Tincture — Morinda citrifolia

Indications (Tincture): Arterial hypertension, anxiety disorder, viral infection of the upper respiratory tract, herpetic infection, mucosal candidiasis, irritable bowel syndrome, hyperlipidemia, chronic prostatitis.

Standard Dosage (Tincture): 15 drops (approximately 0.75 ml) of alcohol tincture twice daily, 20 minutes before meals, diluted in 50 ml of water.

Enhanced Dosage (Tincture): 20 drops 3 times a day, for pronounced viral symptoms, generalized fungal infections, and persistent blood pressure above 140/90 mm Hg.

Maximum Dosage (Tincture): Up to 30 drops 3 times a day. Used short-term (no more than 3 days) for pronounced herpetic relapse, acute prostatitis, and pronounced anxiety with somatic symptoms.

Preventive Dosage (Tincture): 10 drops of alcohol tincture once daily in the morning, for 14 days. Recommended during seasonal viral epidemics, a tendency to mycoses, and chronic prostatitis in the remission phase.

Pediatric Dosage (Tincture): Not recommended for children under 12 years of age. From 12 years — no more than 5 drops once daily, strictly according to indications and under specialist supervision.

Contraindications (Tincture): Alcoholism, hepatic insufficiency, pregnancy, lactation, epilepsy, active gastric and duodenal ulcer. For children under 12 years of age — contraindicated. For patients with hypotension — with caution.

Side Effects (Tincture): Dizziness, dyspepsia, feeling of heat, palpitations. Rare cases of hypotensive crises have been scientifically described when the dosage is exceeded.

Adjustment for Patient Body Weight (Tincture): For body weight below 60 kg, use a 20% lower dosage (approximately 12 drops). For weight above 90 kg, an increase to 25 drops per dose is permissible with tolerance.

Preparation Method (Tincture): To prepare 100 ml of tincture, 20 g of dried Morinda citrifolia fruits, pre-crushed, are taken and poured with 100 ml of 70% ethyl alcohol. Maceration is carried out in dark glassware at room temperature for 10 days with daily shaking. After maceration, the mixture is filtered through gauze and stored in a tightly sealed container. Output volume — 100 ml.

Storage Conditions and Shelf Life (Tincture): Store at a temperature of 15 to 25 degrees Celsius in a dark place, in a tightly closed glass container. Avoid exposure to direct light and EMI. Shelf life — up to 2 years. After opening the package, use within 60 days.


Oil Infusion — Morinda citrifolia

Indications (Oil Infusion): Atopic dermatitis, psoriasis, skin mycosis, acne vulgaris, herpetic infection, trophic ulcer, sunburn, hyperpigmentation, age-related skin changes, scar changes of the epidermis.

Standard Dosage (Oil Infusion): Externally — apply in a thin layer to the affected skin area twice daily, morning and evening, without rinsing. Course of 14–21 days is recommended.

Enhanced Dosage (Oil Infusion): For pronounced inflammations and foci of peeling — apply 3 times a day, rubbing in with light massage movements. Application under a compress at night is permissible for trophic ulcers.

Maximum Dosage (Oil Infusion): Up to 5 applications per day for extensive skin lesions, including psoriatic plaques, chronic dermatitis, and first-degree burns. Course duration no more than 10 days without a break.

Preventive Dosage (Oil Infusion): Once daily, in the evening, rubbing into the skin of the face, neck, hands, or areas with an increased risk of keratinization. Recommended for patients with photosensitivity and mature skin prone to dryness and inflammation. Course — 21 days, with the possibility of repetition after 1 month.

Pediatric Dosage (Oil Infusion): From 3 years — once daily, in a thin layer, on limited skin areas (no more than 5% of body surface). Used for diaper rash, abrasions, insect bites, and atopic dermatitis. Do not apply to mucous membranes and open wounds.

Contraindications (Oil Infusion): Individual intolerance to components, acute purulent skin processes, open bleeding wounds. Data on contraindications during pregnancy, lactation, and in childhood under 3 years of age have not been registered.

Side Effects (Oil Infusion): Rarely — contact dermatitis, itching, erythema, especially with increased sensitivity to fatty acids. When the dose is exceeded, pore congestion with a comedogenic effect is possible.

Adjustment for Patient Body Weight (Oil Infusion): No correction is required, since the form is applied externally. For body weight above 90 kg, it is possible to increase the application area in accordance with the needs.

Preparation Method (Oil Infusion): To prepare 100 g of infusion: take 20 g of dried and crushed peel and seeds of Morinda citrifolia, pour 80 g of organic cold-pressed jojoba oil. Keep the mixture in a glass container in a water bath at a temperature of 40 degrees Celsius for 6 hours with periodic stirring. After infusion, filter through natural cloth, squeeze out the residue, and pour into a sterile dark container.

Storage Conditions and Shelf Life (Oil Infusion): Store in a dark place at a temperature of 5 to 20 degrees Celsius. Avoid exposure to light and heat. After opening, use within 60 days. Protect from contact with metal objects and magnetic fields.


Vaginal Suppositories — Morinda citrifolia

Indications (Vaginal Suppositories): Vaginal candidiasis, bacterial vaginosis, inflammation of the vaginal mucosa, post-antibiotic dysbiotic flora, recurrent vaginitis, herpetic infection of the genital organs.

Standard Dosage (Vaginal Suppositories): 1 suppository (1.5 g) once daily at night for 7 days. Inserted deep into the vagina in a lying position.

Enhanced Dosage (Vaginal Suppositories): 1 suppository twice daily — morning and evening — for acute forms of candidiasis, herpetic infection, or pronounced vaginal discomfort against the background of antibiotic therapy. Course — up to 10 days.

Maximum Dosage (Vaginal Suppositories): Up to 3 suppositories per day is possible under inpatient conditions under medical supervision for recurrent candidiasis, purulent vaginitis, or cytolytic vaginosis. Duration — no more than 5 days.

Preventive Dosage (Vaginal Suppositories): 1 suppository every other day at night for 14 days. Recommended for women in the premenopausal period, after courses of antibiotics, and with a tendency to candidiasis or bacterial vaginosis. Repeat the preventive course no more than once every 3 months.

Pediatric Dosage (Vaginal Suppositories): Not used in pediatric practice. In girls before the onset of puberty, suppositories are contraindicated. Data on use in adolescents over 16 years of age are insufficient.

Contraindications (Vaginal Suppositories): Pregnancy (first trimester), individual intolerance to components, acute bleeding from the genital tract of unclear etiology. Scientific data on safety during lactation and in adolescents are absent.

Side Effects (Vaginal Suppositories): Rare cases of burning and itching in the vagina after insertion, as well as the appearance of abundant mucous discharge. Isolated allergic reactions to plant components have been described.

Adjustment for Patient Body Weight (Vaginal Suppositories): No correction is required. For body weight below 50 kg, an individual reduction in the volume of the suppository to 1 g is possible under specialist supervision.

Preparation Method (Vaginal Suppositories): To prepare 100 g of suppositories: take 10 g of dry Morinda fruit extract, 3 g of cocoa butter, 2 g of shea butter, and 85 g of the main suppository fat (e.g., purified lanolin or organic beeswax). Melt the fat base in a water bath at a temperature not exceeding 50 degrees Celsius, add the crushed extract, and stir thoroughly. Pour into suppository molds with a volume of 1.5 g. Cool until completely solidified.

Storage Conditions and Shelf Life (Vaginal Suppositories): Store at a temperature of 5 to 10 degrees Celsius in the refrigerator, in an airtight package protected from light and foreign odors. Shelf life — up to 6 months. After opening, use within 10 days.


Rectal Suppositories — Morinda citrifolia

Indications (Rectal Suppositories): Chronic prostatitis, hemorrhoids, anal fissure, proctitis, irritable bowel syndrome with a pain component, inflammation of the rectum, neurogenic pain in the pelvic region.

Standard Dosage (Rectal Suppositories): 1 suppository (1.5 g) rectally once daily at night, course of 7–10 days.

Enhanced Dosage (Rectal Suppositories): 1 suppository twice daily (morning and evening), used for pronounced pain syndrome, inflammatory proctitis, and exacerbation of chronic prostatitis. Duration — up to 10 days.

Maximum Dosage (Rectal Suppositories): Up to 3 suppositories per day is possible for pronounced hemorrhoids with inflammation and proctitis, but no more than 5 days and under medical supervision.

Preventive Dosage (Rectal Suppositories): 1 suppository every other day for 14 days. Recommended for patients with recurrent hemorrhoids, a sedentary lifestyle, and a predisposition to congestive phenomena in the lesser pelvis. A preventive course is permissible no more than once a quarter.

Pediatric Dosage (Rectal Suppositories): From 10 years — 0.5 suppository (0.75 g) once daily, in the presence of indications, for example, proctitis or pronounced intestinal spasms. Only as prescribed by a physician.

Contraindications (Rectal Suppositories): Acute rectal bleeding, malignant neoplasms in the anorectal area, individual intolerance to components. Data on safety of use during pregnancy and lactation are insufficient. Use with caution in children under 10 years of age.

Side Effects (Rectal Suppositories): Rarely observed are burning in the rectum, frequent defecation, and false urges. Allergic reactions are possible; cases of local hyperemia have been described.

Adjustment for Patient Body Weight (Rectal Suppositories): For body weight less than 50 kg, a dosage reduction to 1 g of suppository is recommended. For weight over 90 kg, an extension of the course to 14 days at the standard dose is permissible.

Preparation Method (Rectal Suppositories): To obtain 100 g of suppositories, the following are required: 12 g of dry Morinda fruit extract, 3 g of cocoa butter, and 85 g of organic shea butter. Melt the oil base in a water bath at a temperature not exceeding 50 degrees Celsius, then introduce the extract and stir thoroughly until uniform distribution. Pour into molds of 1.5 g. Cool and package in individual blisters.

Storage Conditions and Shelf Life (Rectal Suppositories): Store in the refrigerator at a temperature of 4 to 8 degrees Celsius, in a tightly closed package, without access to light and strong odors. Shelf life — up to 6 months. After opening the package, use within 7–10 days.


Ointments / Creams — Morinda citrifolia

Indications (Ointments / Creams): Psoriasis, acne vulgaris, seborrheic dermatitis, atopic dermatitis, sunburn, skin mycosis, herpetic infection of the lips, hyperpigmentation, trophic ulcer, eczema.

Standard Dosage (Ointments / Creams): Apply to affected skin areas in a thin layer twice daily, morning and evening. Course — from 10 to 21 days depending on the condition.

Enhanced Dosage (Ointments / Creams): 3 times a day with light massage rubbing. In an acute inflammatory process, application under an occlusive dressing is permissible. Used for exacerbations of psoriasis and acute forms of herpetic and fungal lesions.

Maximum Dosage (Ointments / Creams): Up to 5 applications per day is possible for extensive skin lesions (more than 20% of body surface). The maximum permissible course without a break is 10 days, then switch to the standard regimen.

Preventive Dosage (Ointments / Creams): Once daily in the evening — for individuals with chronic skin diseases (psoriasis, atopic dermatitis, hyperpigmentation), as well as for seasonal dry skin. Course — 14 days, can be repeated monthly.

Pediatric Dosage (Ointments / Creams): From 2 years — once daily on limited skin areas. Used for mild forms of dermatitis and mycoses. Do not apply to open wounds and mucous membranes. Monitor the reaction during the first 48 hours.

Contraindications (Ointments / Creams): Individual intolerance, acute purulent skin inflammations, presence of open bleeding wounds. Data on contraindications during pregnancy, lactation, and in children under 2 years of age have not been registered.

Side Effects (Ointments / Creams): Contact dermatitis, hyperemia, burning, and peeling. With frequent use, temporary darkening of the skin is possible due to the antioxidant pigments of the extract.

Adjustment for Patient Body Weight (Ointments / Creams): Not required; the dosage depends on the area of the lesion. In patients with body weight less than 40 kg, it is recommended to reduce the application area for extensive applications.

Preparation Method (Ointments / Creams): For 100 g of ointment: take 15 g of dry Morinda fruit extract, 20 g of cold-pressed coconut oil, 60 g of organic beeswax, and 5 g of calendula oil. Combine the oils and heat in a water bath until the wax is completely dissolved at a temperature of 50 degrees Celsius. Add the extract, stir thoroughly, cool to 40 degrees, and pour into glass jars. Allow to cool at room temperature until completely thickened.

Storage Conditions and Shelf Life (Ointments / Creams): Store in a dark glass jar at a temperature of 5 to 20 degrees Celsius. Avoid overheating and exposure to sunlight. Shelf life — up to 6 months. After opening, use within 45 days.


Serum — Morinda citrifolia

Indications (Serum): Hyperpigmentation, skin photoaging, acne vulgaris, post-acne, dry skin, decreased skin tone, wrinkles, dermatitis with a vascular component.

Standard Dosage (Serum): Apply 3–4 drops to pre-cleansed skin of the face and neck once daily (in the evening). Distribute with light massage movements until completely absorbed. Course — 28 days.

Enhanced Dosage (Serum): Use 2 times a day — morning and evening — is recommended for pronounced pigmentation, pronounced wrinkles, dull complexion, and active acne. Course — up to 42 days.

Maximum Dosage (Serum): Up to 6 drops per application (face, neck, décolleté). Maximum — 2 applications per day. Used no longer than 14 consecutive days without a break, then switch to the standard regimen.

Preventive Dosage (Serum): Once daily every other day, 2 drops, for 21 days. Recommended for patients over 35 years of age, with a tendency to photodamage, seasonal dermatitis, and decreased skin elasticity.

Pediatric Dosage (Serum): Not used in children. From 16 years of age, external use according to indications (acne) is permissible — no more than 2 drops once daily, no more than 14 days.

Contraindications (Serum): Individual intolerance, acute purulent inflammations of the facial skin, combination with aggressive acids and retinoids. Data on contraindications during pregnancy and lactation are insufficient.

Side Effects (Serum): Burning, redness, and skin peeling are possible with individual sensitivity. With excessive application — pore congestion and increased skin oiliness.

Adjustment for Patient Body Weight (Serum): Not required; the form is intended for local application on limited areas. The volume of correction is determined by the application area, not body weight.

Preparation Method (Serum): To obtain 100 ml of serum: take 5 g of dry standardized Morinda extract, 80 ml of witch hazel hydrolate, 10 ml of Morinda seed oil, 3 ml of Centella asiatica extract, and 2 ml of vegetable glycerin. Combine the components in a sterile container and stir thoroughly. If desired, add a natural preservative (0.6 ml of rosemary CO2 extract). Pour into glass dispenser bottles. Sterilization is not required when using only pure ingredients.

Storage Conditions and Shelf Life (Serum): Store in the refrigerator at a temperature of 4 to 8 degrees Celsius. Protect from light and heat. After opening, use within 30 days. Short-term storage outside the refrigerator (up to 48 hours) at a temperature not exceeding 20 degrees is permissible.


Toxicity and Biosafety of Morinda citrifolia

Experimental animal studies have shown that Morinda citrifolia possesses low acute toxicity. The LD50 value of the aqueous fruit extract with oral administration in rats exceeded 5000 mg/kg body weight, which indicates a high degree of safety of the substance when used in traditional doses. Similar results were obtained in assessing the toxicity of lyophilized fruit juice and standardized extracts: at doses up to 2000 mg/kg, no signs of toxic effects, pathological changes in internal organs, or behavior of experimental animals were observed.

Studies of chronic toxicity also indicate good tolerance. In a multicenter trial conducted on rodents and mini-pigs with prolonged administration of Morinda extracts for 90 days, no significant deviations in biochemical and histological parameters were identified. Some publications mention a potential risk of hyperkalemia with excessive consumption of juices, but it is associated mainly with a disturbance of potassium balance in patients with renal insufficiency and does not relate to standard pharmacological forms.

Thus, based on the available data, Morinda citrifolia can be classified as a substance with high biosafety and low acute and chronic toxicity, which confirms the possibility of its wide use in medicine and cosmetology while observing dosages.

Reference: https://www.ncbi.nlm.nih.gov/p...


Pharmacodynamics — Morinda citrifolia

Morinda citrifolia contains a wide range of bioactive substances, including iridoids (especially deacetylasperulosidic acid and aucubin), scopoletin, β-sitosterol, damnacanthal, as well as polyphenols, flavonoids, fatty acids, and amino acids. These compounds determine the complex pharmacodynamic action on key physiological systems of the human body.

One of the most pronounced directions of action of Morinda extracts is antioxidant. Polyphenolic compounds and iridoids demonstrate active inhibition of lipid peroxidation and stabilization of cell membranes, especially under conditions of oxidative stress. This is confirmed by a decrease in the levels of malondialdehyde and an increase in the activity of superoxide dismutase and catalase in tissues. Scopoletin contributes to the enhancement of glutathione synthesis, providing internal redox homeostasis.

With respect to the immune system, modulating effects have been established: the active components of Morinda are capable of changing the expression of cytokines, including a decrease in pro-inflammatory (TNF-α, IL-6) and activation of anti-inflammatory (IL-10), as well as stimulating the phagocytic activity of macrophages and the activity of natural killer (NK) cells. Such effects are supported by the systemic and local action of extracts on immunocompetent tissues.

The pharmacodynamic activity in the nervous system is associated predominantly with the presence of scopoletin, which, according to in vitro and in vivo data, can have a mild sedative, anxiolytic, and antinociceptive effect. The mechanism is presumably associated with modulation of GABA-A receptors, as well as a possible decrease in COX-2 expression in neurons. In addition, damnacanthal is capable of inhibiting tyrosine kinase and modulating the activity of serotonergic mediators, which confirms its influence on mood and pain sensitivity.

At the level of endocrine regulation, the influence of Morinda extracts on the levels of leptin, adiponectin, and tissue insulin sensitivity has been noted. This effect is realized, presumably, through activation of AMPK and a decrease in the expression of pro-inflammatory enzymes in adipocytes, which is important for the regulation of metabolism. An influence on liver enzymes has also been established, including a decrease in ALT and AST activity and an increase in glutathione reductase, which indicates hepatoprotective potential.

On the skin, the extracts exhibit antibacterial and antifungal properties, in particular due to damnacanthal and scopoletin, which inhibit the growth of gram-positive and gram-negative bacteria, as well as yeast-like fungi. In addition, antioxidant components protect keratinocytes from photodamage and stabilize the barrier function of the epidermis.

The pharmacodynamic properties are realized both with local and systemic use. Biological targets include enzymes (COX-2, iNOS), receptors (GABA-A, 5-HT), mediators (cytokines, nitric oxide, interleukins), as well as cellular signaling pathways (MAPK, NF-κB, PI3K/Akt). The mechanisms of action of individual components of Morinda have been studied in in vivo and in vitro pharmacological models, with confirmation of their biological activity and safe profile.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://www.ncbi.nlm.nih.gov/p...
https://www.worldscientific.co...


Pharmacokinetics — Morinda citrifolia

The pharmacokinetics of Morinda citrifolia have been studied to a limited extent; however, based on studies of plant extracts and analysis of known pharmacological groups of its components, a reliable model of the kinetic profile can be constructed.

With oral administration of powder or dry extract, active substances, including iridoids, phenolic compounds, and flavonoids, undergo absorption predominantly in the small intestine. This process is mediated by passive diffusion, with the participation of ion transporters, and may also depend on the pH of the medium and the solubility of individual fractions. Some components, such as complex polyphenols, are partially metabolized by the intestinal microflora to more bioavailable metabolites.

Enzymatic transformation begins already in the intestinal mucosa, where catechol-O-methyltransferases, β-glucuronidases, and sulfotransferases carry out preliminary conjugation. The main metabolism occurs in the liver in phases I and II with the participation of cytochrome P450, which suggests a possible influence on the kinetics of other substances with simultaneous intake.

The distribution of active substances depends on the lipophilicity of the fractions. Some iridoids and fat-soluble compounds (e.g., compounds extracted by oil infusion) are capable of penetrating the blood-brain barrier, exerting a systemic effect, including an influence on the central nervous system. Phenolic compounds are predominantly distributed in the liver, skin, mucous membranes, and lymphoid tissue. Active substances can partially bind to plasma albumins, but most circulate in free form or as glucuronides and sulfates.

With transdermal and mucosal administration (ointment, serum, vaginal suppositories), absorption is local and depends on the degree of hydrophilicity of the base, the presence of an inflammatory process, and the surface temperature of the skin. Fat-soluble components penetrate deeper, localizing in the epidermis and subcutaneous fat. Vaginal forms are characterized by partial systemic absorption through the vaginal mucosa, with entry into the venous bed of the lesser pelvis and further metabolism in the liver.

Components absorbed systemically undergo metabolism in the liver with subsequent excretion by the kidneys in the form of metabolites or unchanged. Some lipophilic fractions and fatty acid derivatives can be excreted with bile and further reabsorbed in the intestine (enterohepatic circulation). Small amounts of volatile metabolites can be released through the lungs or skin. Evidence of accumulation in tissues with prolonged use at therapeutic doses has not been identified.

Thus, the pharmacokinetics of Morinda citrifolia reflects the properties of multicomponent plant complexes with predominant absorption in the intestine, hepatic metabolism, and predominant excretion through the kidneys and bile. External forms act predominantly locally, with limited systemic absorption.

References:
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://www.ncbi.nlm.nih.gov/p...
https://www.worldscientific.co...
https://www.ncbi.nlm.nih.gov/p...


Mechanisms of Action and Scientific Rationale — Morinda citrifolia

The mechanisms of action of Morinda citrifolia are determined by the multicomponent composition, including iridoids, scopoletin, damnacanthal, flavonoids, β-sitosterol, as well as a number of fatty acids and antioxidant phenols. One of the key pharmacological directions of action is the inhibition of pro-inflammatory cascades through suppression of the transcription factor NF-κB. In vitro studies demonstrate that damnacanthal and iridoid glycosides suppress the expression of COX-2 and iNOS in macrophages, thereby reducing the production of pro-inflammatory mediators — nitric oxide and prostaglandins. This provides an anti-inflammatory and modulating effect at the tissue level.

Reference: https://www.ncbi.nlm.nih.gov/p...

Scopoletin, found in fruit extracts, participates in the regulation of dopaminergic and serotonergic signaling pathways. Experimental models show that the substance is capable of enhancing the expression of 5-HT1A receptors and reducing the activation of the MAPK cascade, which is associated with the normalization of neurotransmitter transmission. Scopoletin also increases the intracellular level of glutathione and activates the antioxidant response mediated by Nrf2, which plays a key role in protecting neurons and the endothelium from oxidative stress.

Reference: https://www.sciencedirect.com/...

The iridoids contained in Morinda influence the immune system through the regulation of cytokine balance. It has been shown that these compounds are capable of reducing the secretion of TNF-α and IL-6 while simultaneously increasing IL-10, thereby switching the immune response from a Th1 profile to a more balanced one. This is also accompanied by a decrease in the expression of Toll-like group receptors (TLR4) on the surface of macrophages and monocytes. Such effects indicate the potential for immunoneutralization and control of chronic inflammation.

Reference: https://www.tandfonline.com/do...

Lipophilic components of the extract (e.g., damnacanthal and β-sitosterol) are capable of modulating enzymatic activity in adipose and liver tissue. In vivo studies demonstrate inhibition of lipogenesis enzymes, such as acetyl-CoA carboxylase and HMG-CoA reductase, which reduces the synthesis of fatty acids and cholesterol. These same compounds activate the AMPK pathway, an important metabolic regulator of cellular energy metabolism, and influence the expression of adipokines, including leptin and adiponectin.

Reference: https://www.ncbi.nlm.nih.gov/p...

On the skin, the components of Morinda extracts demonstrate antibacterial and antifungal properties associated with direct inhibition of protein synthesis in bacteria and destruction of the fungal cell wall. Damnacanthal disrupts the ion balance in the cytoplasm of bacteria and disrupts the activity of bacterial proteases, which leads to cell lysis. In addition, the extracts inhibit the formation of biofilms of pathogens such as Candida albicans and Staphylococcus aureus, which makes the plant promising in dermatological and antimicrobial therapy.

Reference: https://www.sciencedirect.com/...

Thus, the biological activity of Morinda citrifolia is realized through an influence on enzyme and receptor systems, signaling cascades, and mediator processes, covering nervous, immune, skin, endocrine, and digestive regulation. These actions have been confirmed by both experimental and biochemical studies and reflect pharmacological activity at the level of cellular targets and molecular processes.

References: https://www.ncbi.nlm.nih.gov/p...; https://www.worldscientific.co...;https://www.ncbi.nlm.nih.gov/p...


Synergy — Morinda citrifolia

The pharmacological synergy of Morinda citrifolia has been confirmed in a number of preclinical and experimental studies when combined with other plant extracts, biologically active substances, and natural compounds. The most pronounced interactions have been noted in the directions of antioxidant, anti-inflammatory, immunomodulatory, and neuroprotective activity. The mechanisms of synergy cover both direct enhancement of effects due to simultaneous action on receptor and enzyme targets and indirect potentiation through metabolic and signaling cascades.

In vitro experimental data show that the combination of Morinda citrifolia extract with green tea flavonoids demonstrates a potentiating effect on the inhibition of lipid peroxidation and enhancement of the activity of endogenous antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase). Such interaction is explained by the activation of the Nrf2 signaling pathway and modulation of redox homeostasis at the cellular level.

Reference: https://www.ncbi.nlm.nih.gov/p...

When combined with curcumin, an enhancement of the anti-inflammatory effect has been established, manifested in a more pronounced suppression of COX-2 and TNF-α expression in macrophages. The mechanism suggests a joint influence on the transcription factor NF-κB and the MAPK signaling pathway, which leads to a synergistic reduction in the inflammatory response. Similar effects have been recorded in studies with the combination of Morinda and boswellic acid, where a complementation of the inhibitory action on LOX and a decrease in leukotriene formation were observed.

Reference: https://www.sciencedirect.com/...

In the immunomodulatory direction, synergy has been revealed between Morinda citrifolia and Echinacea purpurea extracts, where an additive effect on the activation of phagocytic activity, increased expression of IL-10, and normalization of IFN-γ levels is substantiated. In vivo studies confirm that this interaction is realized at the level of the T-cell response and stabilization of regulatory cytokine profiles.

Reference: https://www.tandfonline.com/do...

Separate attention deserves the combination with magnesium and B vitamins, where neurotropic synergy is observed, expressed in a decrease in behavioral and cognitive impairments in animals. It is believed that this is due to the joint action on serotonergic and dopaminergic neurotransmission, as well as modulation of glutamate receptors.

Reference: https://www.springer.com/gp/bo...

With external application, a synergistic enhancement of antibacterial action has been recorded when combined with tea tree and lavender oils. In vitro studies show that such mixtures have greater effectiveness in inhibiting the growth of gram-positive bacteria, including Staphylococcus aureus, compared to mono-extracts. The mechanism is based on the destruction of the cell membrane and disruption of bacterial protein synthesis.

Reference: https://www.ncbi.nlm.nih.gov/p...

Thus, the synergy of Morinda citrifolia is realized at the systemic and cellular levels, including enzyme and receptor interactions, activation of signaling pathways, and enhancement of the barrier and trophic activity of tissues. This is substantiated both biochemically and functionally, which makes the taxon a promising component for multicomponent preparations.


Geography of Use and Traditional Medicine — Morinda citrifolia

Morinda citrifolia is one of the most well-known ethnomedical plants of the Pacific region and Southeast Asia. Its traditional use covers the island cultures of Polynesia, Micronesia, Melanesia, as well as the regions of Indonesia, the Philippines, South India, Sri Lanka, and Thailand. In these cultures, Morinda is known under various local names, including "noni" (in the Hawaiian, Samoan, and Tahitian tradition), "yo" (in Thai medicine), and "Indian mulberry" (in South Indian phytotherapy), and is considered a plant with a multi-purpose action — nutritional, medicinal, and ritual.

Historical information on the use of Morinda citrifolia dates back, according to available data, to the prehistoric period of Polynesian migration. Archaeoethnobotanical finds made in the Marquesas Islands and Eastern Polynesia indicate the purposeful spread of the plant as part of the "botanical baggage" of the settlers. Oral traditions of Samoa and Tahiti contain mentions of the use of Morinda as a plant that grants strength and protection, and its fruits and leaves often accompanied rites of passage, purification, and appeals to ancestors.

In folk medicine, the juice of Morinda fruits was used for rubbings, compresses, and was also consumed internally as a general remedy for "purification" and "balancing the inner fire." The leaves were used in the form of poultices and wraps and applied to inflamed skin areas. In the traditions of the Maori and Samoans, Morinda leaves were often added to ritual herbal baths intended for the protection of newborns and the purification of women in labor. Among the Aborigines of Australia, Morinda fruits were part of smoking and fumigating mixtures and were also used in the form of juice when applying sacred patterns to the body.

In South Asian medical systems, including Siddha and Ayurveda, Morinda citrifolia was considered a plant affecting all three doshas and was used in oil infusions, pastes, and infusions. In Indonesian and Malay practice, Morinda leaves were used as part of "jamu" — a complex of traditional phyto-remedies passed down through the female line. Decoctions of the plant's roots were used for fumigating dwellings, especially during illness or loss, for the purpose of purifying space and expelling "impure spirits."

In Thai traditional medicine, Morinda citrifolia is widely used in both the northern and southern regions. The fruit infusion is considered a universal tonic, and the leaves are used in the form of decoctions and wraps. In the culture of the Lanna peoples, Morinda was revered as a "female plant" and was often used in postpartum practices. Its use in ritual offerings to ancestral spirits is also noted, especially in regions with a strong influence of animistic traditions.

In addition to medicinal use, Morinda has a symbolic significance as a plant of longevity that protects against "spiritual diseases" and contributes to the restoration of inner balance. Ethnographic descriptions mention the application of a paste of Morinda fruits to the bodies of participants in rites of expulsion, for the purpose of energetic "isolation" and protection from the influence of evil forces. In many cultures, the plant is considered a plant of strength and purification, and its fruits — a sacred source of energy granted by the gods.

Specifications
Product type Powder, Extract
Weight 100 g
Made by Asiabiopharm Co Ltd
Country of origin Thailand
Reviews